CATEGORIES

Pharma's strategic path to growth in the nutra maze

The nutraceutical market is a thriving ecosystem of opportunities. For pharma companies, it's a space where the allure of a $11.55 billion pie by 2030 is tempered by a maze of regulatory grey zones, stiff competition, and trust-eroding marketing practices.

PRIME NEO from Gandhi Automations

Gandhi Automation's PRIME NEO High Speed Doors are designed to provide superior sealing and resistance to pressure differences for clean rooms. And the added advantage is that it is absolutely washable

AI smart camera for real-time automation

Integrated asset management functionality and a deep learning tool for training and evaluation keep productivity high and costs low

PROSOLV® 730: Directly compressible carrier for lipophilic ingredients

Nearly 90% of molecules in the discovery pipeline and 40% of drugs with market approval are poorly water soluble.

Complete environmental monitoring solution - testo Saveris Pharma

testo Saveris Pharma monitors and documents temperature, humidity, differential pressure, and other parameters without interruption and compliantly with GxP so that audits and inspections are conducted smoothly

The unmissable Asia healthcare opportunity

BCG's latest report, The Unmissable Asia Healthcare Opportunity, highlights the region's $5 trillion healthcare market potential by 2030, driven by demographic shifts, investment, and innovation.

2025: Healthcare and Lifesciences investment outlook

Kapil Khandelwal, Managing Partner, Toro Finserve and EquNev Capital, interprets the possibilities for the various segments of the Indian lifesciences and healthcare sector for this year

The group's offerings range from over a billion injection doses annually to bespoke medical machinery

Rishad Dadachanji, MD, Dadachanji Group speaks on the company's evolution from a pharma packaging company to a diversified solutions provider in biotechnology, automation, and sterile processing.

DECODING THE M&A LANDSCAPE

Consolidation has emerged as a major trend as the pharma industry seeks new avenues of growth and looks to expand its existing capabilities.

Evolution and commercialisation of cell and gene therapies

Satyen Sanghavi, Founder & CSO, Regrow Biosciences traces the evolution of cell and gene therapies, highlighting global milestones, industry growth, and reimbursement models.

Our vision is to make cutting-edge therapies accessible to Indian patients

Amit Mookim, CEO, Immuneel Therapeutics, discusses the launch of Qartemi, India's first CAR T-cell therapy, and the company's vision to make advanced cell and gene therapies accessible and affordable for Indian patients.

CILICANT is changing the way we think about active packaging

Team CILICANT shared insights into their journey of innovation, customer-centric solutions, and their ambitious plans for global expansion. In this engaging dialogue, the team also shed light on their unique value proposition, recent achievements, and strategies for adapting to a rapidly evolving pharma landscape, in an exclusive conversation with Express Pharma

KPMG 2024 Life Sciences CEO Outlook

This recent KPMG report explores the perspectives and priorities of life sciences CEOs amid economic and geopolitical uncertainty, focusing on growth strategies, digital transformation, ESG goals, and workforce challenges. Excerpts from the report

Nutraceuticals 2025: Mapping growth, innovation, and consumer-centric trends

Industry experts highlight the evolving dynamics, regulatory needs, and personalised solutions driving the nutra market ahead of 2025

We aim to strengthen our presence in Asian and MENA regions, with particular emphasis on India

Matthias Poslovski, Chief Sales Officer, Optima Pharma, speaks on the company's evolution and shares insights on emerging trends like personalised medicine, digitalisation, and Al-driven technologies, while outlining his company's strategies for market expansion, particularly in Asia and MENA, with a focus on the Indian pharma sector, in an exclusive interaction with Lakshmipriya Nair

Sustaining excellence: The evolving role of quality in pharma

In the ever-evolving landscape of the pharma industry, the pursuit of quality remains a cornerstone of success. As stringent regulatory frameworks, rising patient expectations, and the increasing pace of innovation, transforms the pharma industry, the definition of quality is also evolving. From ensuring compliance with global standards to embracing cutting-edge technologies like Al-driven quality control, the industry is navigating a paradigm shift in how it approaches product integrity, safety, and efficacy. In this New Year issue, pharma experts explore how crucial it is to foster a culture of quality across organisations and deliver better healthcare outcomes

Revolutionising pharma the adaptive way

Adaptive manufacturing offers better performance, efficient management of diverse products, a reduced machine footprint, faster batch changes, and enhanced operational sustainability

Trends 2025: Redefining the pharma supply chain

Saurabh Gupta, Global Head of Supply Chain, Lupin highlights trends such as Al integration, digitalisation and sustainability that are shaping a future-ready supply chain

Growth mantras for 2025: Innovation, Partnerships, Sustainability

Innovation, synergy, and sustainability are shaping the trajectory of India's pharma sector, unlocking new frontiers of growth, inform industry stakeholders

Will Epygen's biosimilars bets pay off?

Debayan Ghosh, founder, Epygen Group, has ambitious plans to snag a slice of the booming $70 billion global biosimilar pie. In a conversation with Viveka Roychowdhury, he analyses the journey so far, spanning pandemic preparedness projects like protein-based vaccines, building up pipeline revenue streams in diabetes, oncology, immunology and cardiovascular biosimilars, and his strategies to scale up and expand to other therapeutics like anti-obesity drugs

Innovation, partnerships and best practices: Priorities for biopharma in 2025

Industry experts highlight the progress made by the Indian biopharma sector, and suggest pathways to promote growth

Blissfill-Calibrated syringe pipettes for repetitive laboratory dosing as per ISO 8655-9

Blissfill syringe pipettes provide laboratories with an ergonomic, self-refilling solution for repetitive dosing, delivering precise volumes from 0.05ml to 10ml. With ISO 8655-9 compliance and an included calibration certificate, Blissfill ensures accuracy and ease of use for high-demand lab applications

Ensuring pharma compliance with testo data measurement technology

Comprehensive data measurement tools address regulatory demands and secure quality in pharma

Waters launches software for lab-centric business intelligence enabling audit readiness

waters_connect Data Intelligence software provides laboratories with comprehensive business intelligence on their chromatographic data throughout the product development lifecycle, enabling real-time audit readiness and query response, while reducing time spent on audit preparation

Ensuring clean room integrity with Prime Clean Reset High-Speed Doors

Designed with precision to meet the stringent requirements of controlled environments, Prime Clean Reset is the epitome of performance and reliability, ensuring that your clean room operations consistently meet the highest standards of regulatory compliance and product integrity

Optimising efficiency with Remote Laboratory Solutions

LabWare's comprehensive suite of software solutions designed specifically for laboratories offers reliable Remote Laboratory Solutions to help your business thrive in the current climate

Ensuring water quality with the 6000TOCi: The ultimate solution for continuous TOC measurement

The 6000TOCi Sensor is a comprehensive solution that brings together continuous monitoring, rapid response, reliability, and compliance

Enhancing pharmaceutical analysis in critical areas

Dheeraj Handique, Manager GC/GCMS Product Marketing, Shimadzu Analytical (India) highlights the benefits of GCMS-TQ8050 NX with HS-20 NX trap for genotoxic impurities, nitrosamines, and, extractables and leachables

Technical innovations for Annex 1

To meet the stringent EU GMP Annex 1 requirements, Optima presents innovative solutions to improve product and patient safety in pharmaceutical manufacturing. From minimising glove interventions and optimising First Air flow to advanced automation for integrity testing, this article explores how Optima's technologies support compliance in aseptic fill-and-finish processes

JRS Pharma - The Global MCC Manufacturing Network

JRS Pharma is one of the largest manufacturers of MCC across the globe. The know-how is based on more than 25 years of experience in development of own processes